Imexpharm Corporation (HOSE:IMP)
34,400
-250 (-0.72%)
At close: Nov 18, 2026
Imexpharm Revenue
Imexpharm had revenue of 543.65B VND in the quarter ending September 30, 2026, a decrease of -5.21%. This brings the company's total for the last twelve months to 2.29T, down -6.50% year-over-year. In the year 2025, Imexpharm had annual revenue of 2.44T with 10.70% growth. That makes Imexpharm the 23,594th largest company in the world by revenue and 242nd in Vietnam.
Revenue (ttm)
2.29T
Revenue Growth
-6.50%
P/S Ratio
2.33
Revenue / Employee
1.58B
Employees
1,453
Market Cap
5.30T
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.44T | 235.97B | 10.70% |
| Jan 1, 2025 | 2.21T | 211.08B | 10.59% |
| Jan 1, 2024 | 1.99T | 350.33B | 21.31% |
| Dec 31, 2022 | 1.64T | 377.11B | 29.77% |
| Dec 31, 2021 | 1.27T | -102.83B | -7.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| DHG Pharmaceutical JSC | 5.33T |
| Traphaco JSC | 2.79T |
| Ha Tay Pharmaceutical JSC | 2.38T |
| Domesco Medical Import - Export Joint-Stock | 2.17T |
| Binh Dinh Pharmaceutical and Medical Equipment JSC | 1.89T |
| Cuu Long Pharmaceutical JSC | 1.32T |
| OPC Pharmaceutical JSC | 1.14T |
| Vidipha Central Pharmaceutical JSC | 1.01T |